Homo-and heterodimerization of the opioid receptors with functional consequences were reported previously. However, the exact nature of these putative dimers has not been identified. In current studies, the nature of the heterodimers was investigated by producing the phenotypes of the 1:1 heterodimers formed between the constitutively expressed -opioid receptor (MOR) and the ponasterone A-induced expression of ␦-opioid receptor (DOR) in EcR293 cells. By examining the trafficking of the cell surface-located MOR and DOR, we determined that these two receptors endocytosed independently. Using cell surface expression-deficient mutants of MOR and DOR, we observed that the corresponding wild types of these receptors could not rescue the cell surface expression of the mutants, whereas the antagonist naloxone could. Furthermore, studies with constitutive or agonist-induced receptor internalization also indicated that MOR and DOR endocytosed independently and could not "drag in" the corresponding wild types or endocytosis-deficient mutants. Additionally, the heterodimer phenotypes could be eliminated by the pretreatment of the EcR293 cells with pertussis toxin and could be modulated by the deletion of the RRITR sequence in the third intracellular loop that is involved in the receptor-G protein interaction and activation. These data suggest that MOR and DOR heterodimerize only at the cell surface and that the oligomers of opioid receptors and heterotrimeric G protein are the bases for the observed MOR-DOR heterodimer phenotypes.The ability of G protein-coupled receptors (GPCRs) 1 to homoor heterodimerize has implications in the functions of the receptors. Dimerization of the receptors has been reported for the class A GPCRs such as the adenosine (1), adrenergic (2-5), angiotensin (6), dopamine (7,8), muscarinic (9), vasopressin (2, 10), and opioid (11-15) receptors and the class C GPCRs such as the calcium-sensing (16), the metaboropic glutamate receptors (17), and the ␥-amino-n-butyric acid type B (GABA B ) receptors (18 -20). The homo-and heterodimerization of these receptors have been demonstrated by co-immunoprecipitation experiments (11, 21) and subsequently by the fluorescence resonance energy transfer or bioluminescence resonance energy transfer techniques (3,12,23). The heterodimerization of the GPCRs was shown to be selective, with formation of heterodimers with some but not all subtypes of the receptors (13, 24, 25). Most importantly, there are functional differences between the monomers and the homo-and heterodimers of the GPCRs. The classic example is the inability of individual GABA B1 and GABA B2 subunit to form a functional receptor (18 -20). Alteration in the GPCR function or expression was also observed with the heterodimerization of 5HT1B and -1D (26), dopamine D1 and adenosine A1 (27), muscarinic M2 and M3 (28), or dopamine and somatostatin (29) receptors. Heterooligomerization of the GPCRs with other receptor types, such as the ionotropic GABA A receptor, has been observed, resulting in the alteration ...